Genitourinary System Neoplasm — Trials

Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

17,388 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 401–450 of 1,312 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05501054	Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.	active not recruiting	Phase 1 / Phase 2	50	M.D. Anderson Cancer CenterOTHER	1	Jul 16, 2026	clinicaltrials
NCT05843448	IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer	active not recruiting	Phase 1	6	University of California, DavisOTHER